drugset / Trial / NCT02252926

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

NCT02252926

RandomizedParallel-groupOpen-labelSupportive care

Summary

Oral mucositis is a damage to the mucosa of the oral cavity and pharynx. It is a serious and painful adverse effect caused by the radio therapy and/or chemo therapy patients with head and neck cancer receive. The pain caused by oral mucositis can be difficult to treat as the current treatment with opioids is not sufficient and can cause adverse effects. Our hypothesis is that treatment with a local anesthetic lozenge with bupivacaine can reduce the oral pain caused by mucositis compared with the current standard treatment.

Timeline

Start
2014-09
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 25 mg Other
Background Acetaminophen Small molecule
Background Gabapentin Small molecule
Background Lidocaine Other / unclassified
Background Morphine Other / unclassified

Indications